Abstract
Allosteric inhibition of protein tyrosine phosphatase 1B (PTP1B), has paved a new path to design specific inhibitors for PTP1B, which is an important drug target for the treatment of type II diabetes and obesity. The PTP1B1–282-allosteric inhibitor complex crystal structure lacks α7 (287–298) and moreover there is no available 3D structure of PTP1B1–298 in open form. As the interaction between α7 and α6–α3 helices plays a crucial role in allosteric inhibition, α7 was modeled to the PTP1B1–282 in open form complexed with an allosteric inhibitor (compound-2) and a 5 ns MD simulation was performed to investigate the relative orientation of the α7–α6–α3 helices. The simulation conformational space was statistically sampled by clustering analyses. This approach was helpful to reveal certain clues on PTP1B allosteric inhibition. The simulation was also utilized in the generation of receptor based pharmacophore models to include the conformational flexibility of the protein-inhibitor complex. Three cluster representative structures of the highly populated clusters were selected for pharmacophore model generation. The three pharmacophore models were subsequently utilized for screening databases to retrieve molecules containing the features that complement the allosteric site. The retrieved hits were filtered based on certain drug-like properties and molecular docking simulations were performed in two different conformations of protein. Thus, performing MD simulation with α7 to investigate the changes at the allosteric site, then developing receptor based pharmacophore models and finally docking the retrieved hits into two distinct conformations will be a reliable methodology in identifying PTP1B allosteric inhibitors.
Similar content being viewed by others
References
Cicirelli MF, Tonks NK, Diltz CD, Weiel JE, Fischer EH, Krebs EG (1990) Proc Natl Acad Sci USA 87:5514. doi:10.1073/pnas.87.14.5514
Ahmad F, Li PM, Meyerovitch J, Goldstein BJ (1995) J Biol Chem 270:20503. doi:10.1074/jbc.270.35.20503
Johnson TO, Ermolieff J, Jirousek MR (2002) Nat Rev Drug Discov 1:696. doi:10.1038/nrd895
Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, Haj F, Wang Y, Minokoshi Y et al (2002) Dev Cell 2:489. doi:10.1016/S1534-5807(02)00148-X
Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL et al (1999) Science 283:1544. doi:10.1126/science.283.5407.1544
Hooft van Huijsduijnen R, Sauer WH, Bombrun A, Swinnen D (2004) J Med Chem 47:4142. doi:10.1021/jm030629n
Frangioni JV, Beahm PH, Shifrin V, Jost CA, Neel BJ (1992) Cell 68:545. doi:10.1016/0092-8674(92)90190-N
Iversen LF, Moller KB, Pedersen AK, Peters GH, Petersen AS, Andersen HS et al (2002) J Biol Chem 277:19982. doi:10.1074/jbc.M200567200
Asante-Appiah E, Ball K, Bateman K, Skorey K, Friesen R, Desponts C et al (2001) J Biol Chem 276:26036. doi:10.1074/jbc.M011697200
Sun JP, Fedorov AA, Lee SY, Guo XL, Shen Lawrence DS, Almo SC et al (2003) J Biol Chem 278:12406. doi:10.1074/jbc.M212491200
Puius YA, Zhao Y, Sullivan M, Lawrence DS, Almo SC, Zhang ZY (1997) Proc Natl Acd Sci 94:13420. doi:10.1073/pnas.94.25.13420
Asante-Appiah E, Patel S, Desponts C, Taylor JM, Lau C, Dufresne C et al (2006) J Biol Chem 281:8010. doi:10.1074/jbc.M511827200
Wrobel J, Sredy J, Moxham C, Dietrich A, Li Z, Sawicki DR et al (1999) J Med Chem 42:3199. doi:10.1021/jm990260v
Wiesmann C, Barr KJ, Kung J, Zhu J, Erlanson DA, Shen W et al (2004) Nat Struct Mol Biol 11:730. doi:10.1038/nsmb803
Barford D, Flint AJ, Tonks NK (1994) Science 263:1397. doi:10.1126/science.8128219
Jia Z, Barford D, Flint AJ, Tonks NK (1995) Science 268:1754. doi:10.1126/science.7540771
Kolmodin K, Aqvist J (2001) FEBS Lett 498:208. doi:10.1016/S0014-5793(01)02479-6
Montalibet J, Skorey K, McKay D, Scapin G, Asante-Appiah E, Kennedy B (2006) J Biol Chem 281:5258. doi:10.1074/jbc.M511546200
Kamerlin KCL, Rucker R, Boresch S (2006) Biochem Biophys Res Commun 345:1161. doi:10.1016/j.bbrc.2006.04.181
Kamerlin KCL, Rucker R, Boresch S (2007) Biochem Biophys Res Commun 356:1011. doi:10.1016/j.bbrc.2007.03.093
Deng J, Lee KW, Sanchez T, Cui M, Neamati N, Briggs JM (2005) J Med Chem 48:1496. doi:10.1021/jm049410e
Berendsen HJC, van der Spoel D, van Drunen R (1995) Comput Phys Commun 91:43. doi:10.1016/0010-4655(95)00042-E
van der Spoel D, Lindahl E, Hess B, van Buuren AR, Apol E, Meulenhoff PJ, et al (2005) Gromacs User Manual version 3.3, http://www.gromacs.org
Schuettelkopf AW, van Aalten DMF (2004) Acta Crystallogr D Biol Crystallogr 60:1355. doi:10.1107/S0907444904011679
Discovery Studio 1.7, Accelrys Inc., San Diego, CA, USA
CATALYST 4.11, Accelrys Inc., San Diego, CA, USA
Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) J Mol Biol 267:727. doi:10.1006/jmbi.1996.0897
Bharatham N, Bharatham K, Lee KW (2007) J Mol Graph Model 25:813. doi:10.1016/j.jmgm.2006.08.002
Bharatham N, Bharatham K, Lee KW (2007) Arch Pharm Res 30:533
Bharatham K, Bharatham N, Park KH, Lee KW (2008) J Mol Graph Model 26:1202. doi:10.1016/j.jmgm.2007.11.002
Acknowledgements
Kavitha Bharatham and Nagakumar Bharatham were recipients of fellowships from the BK21 Programs and this work was supported by grants from the MOST/KOSEF for the Environmental Biotechnology National Core Research Center (grant #:R15-2003-012-02001-0).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
10822_2008_9229_Fig8_ESM.jpg
Docking conformations of compound-1 (yellow) and compound-3 (grey) in the initial structure (a and d) and cluster 10 representative structure (b and d). The mapping of compounds onto CLU10HYPO (c and f) respectively. The allosteric site is represented by α3, α6, α7 shown as ribbons and the interacting residues are shown as sticks (JPG 1743 kb)
Rights and permissions
About this article
Cite this article
Bharatham, K., Bharatham, N., Kwon, Y.J. et al. Molecular dynamics simulation study of PTP1B with allosteric inhibitor and its application in receptor based pharmacophore modeling. J Comput Aided Mol Des 22, 925–933 (2008). https://doi.org/10.1007/s10822-008-9229-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-008-9229-0